Fed. Circ. Nixes PTAB Remand In Settled Eye Drug Case
In a move described as atypical, the Federal Circuit on Tuesday partially tossed a Patent Trial and Appeal Board decision upholding a Paragon BioTeck eye solution patent challenged by Altaire Pharmaceuticals...To view the full article, register now.
Already a subscriber? Click here to view full article